Boehringer Ingelheim
Andrew Bertolini is an experienced professional in the pet pharmaceuticals industry, currently serving as the National Brand Manager for Pets at Boehringer Ingelheim since October 2018. Prior to this role, Andrew held various positions at Elanco, including Marketing Brand Manager and Territory Sales & Key Account Manager in Companion Animal Health. Earlier experience includes roles in sales and account management at Life Technologies, as well as quality assurance at Anheuser-Busch InBev. Andrew's educational background includes a Master of Science in Stem Cell Biology and a Bachelor of Science in Biological Sciences from the University of Guelph. Andrew's diverse skill set encompasses sales, marketing, customer relations, and team management, contributing to significant achievements throughout the career.
This person is not in any teams
This person is not in any offices
Boehringer Ingelheim
116 followers
At Boehringer Ingelheim they create value through innovation with one clear goal: to improve the lives of patients. They develop breakthrough therapies and innovative healthcare solutions in areas of unmet medical need for both humans and animals. As a family owned company, they focus on long-term performance. They are powered by 50.000 employees globally who nurture a diverse, collaborative and inclusive culture. Learning and development for all employees is key, because your growth is their growth.